ViralZone Archives - Page 49 of 64 - Virology Hub
ViralZone
0
New Yorkers and Coronavirus — Support for school closures, while most feel not at risk
0

A new survey released today found that 60% of New York State residents believe their chances of contracting the novel Coronavirus are low or very low. The ...

0
Scientists find ally in fight against brain tumors: Ebola
0

Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Scientists have enlisted a most unlikely ally in efforts to treat this form of ...

0
Highly active HIV antibody restricts development of viral resistance
0

Antiretroviral drugs are the gold standard for the treatment of HIV infection. They are highly effective in suppressing replication of the virus but require ...

0
Eco-friendly way to stop mosquitoes
0

An innovative -- and inexpensive -- technique targets mosquito larvae where they live. Source link

0
Cincinnati Children’s Research Foundation: Postdoctoral Fellowship Opportunity in Translational Research
0

NIH Scale for postdoc + competitive benefits package with paid time off.: Cincinnati Children's Research Foundation: Immediate opening for postdoctoral ...

0
Religiousness linked to improved quality of life for people with HIV
0

Adults living with HIV in Washington, D.C., were more likely to feel higher levels of emotional and physical well-being if they attended religious services ...

0
Remdesivir prevents MERS coronavirus disease in monkeys
0

The experimental antiviral remdesivir successfully prevented disease in rhesus macaques infected with Middle East respiratory syndrome coronavirus (MERS-CoV), ...

0
HIV antibody therapy is associated with enhanced immune responses in infected individuals
0

Most people living with HIV control the virus thanks to antiretroviral therapy (ART). Although this medication is highly effective, the presence of latent ...

0
Spread of coronavirus underestimated, review finds
0

The coronavirus probably has a stronger ability to spread than the World Health Organization has estimated so far, according to a review of previous studies ...

0
Vulnerability in healthcare of migrants living with HIV
0

Migrants living with HIV are a particularly vulnerable group in Sweden and Swedish health care, research from the University of Gothenburg shows. How they ...

0
New pathogenic mechanism for influenza NS1 protein found
0

Researchers report the biological effects of influenza protein NS1 binding to RIG-I -- the binding directly quiets the alarm that activates the cellular ...

0
Costs of ART regimens increasing, outpacing inflation
0

(HealthDay)—Initial regimens recommended for most people with HIV (PWH) are priced above $36,000 per year, with antiretroviral therapy (ART) cost increases ...

Virology Hub
Logo
Enable registration in settings - general